Exchange: NYSE·Updated 07:30 PM EDT
Latest Earnings Results: Q2 '26

Reported: Aug 05

Estimated EPS

$2.01

Reported EPS

$2.07

Surprise

+2.97%

Estimated Rev

$2.13B

Reported Rev

$2.18B

Surprise

+1.97%

• Reported GAAP EPS of $1.03 up 33.77% YoY • Reported revenue of $2.18B up 4.80% YoY • Zimmer Biomet Holdings, Inc. updated its full-year 2026 guidance, raising reported revenue growth to 3.9%-4.9% and adjusted diluted EPS to a range of $8.47-$8.59, reflecting confidence in its ongoing business momentum.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
$1.88
--
--
N/A
Q2 '26
$2.01
$2.07
2.97%
BEAT
Q1 '26
$1.87
$2.09
12.05%
BEAT
Q4 '25
$2.40
$2.42
0.92%
BEAT
Q3 '25
$1.87
$1.90
1.82%
BEAT

Advertisement|Remove ads.